Prognostic significance of carcinoembryonic antigen levels in peritoneal washes in patients with gastric cancer

Citation
N. Abe et al., Prognostic significance of carcinoembryonic antigen levels in peritoneal washes in patients with gastric cancer, AM J SURG, 181(4), 2001, pp. 356-361
Citations number
21
Categorie Soggetti
Surgery,"Medical Research Diagnosis & Treatment
Journal title
AMERICAN JOURNAL OF SURGERY
ISSN journal
00029610 → ACNP
Volume
181
Issue
4
Year of publication
2001
Pages
356 - 361
Database
ISI
SICI code
0002-9610(200104)181:4<356:PSOCAL>2.0.ZU;2-Q
Abstract
Background: Peritoneal metastasis is the most frequent cause of death in pa tients with gastric cancer. Detection of free cancer cells in the peritonea l cavity at the time of surgery, therefore, is considered to be of great va lue in predicting the peritoneal recurrence and accordingly in the prognosi s in patients with gastric cancer. This study examined the clinical signifi cance of intraoperative determination of carcinoembryonic antigen (CEA) lev els in peritoneal washes (pCEA) in patients with gastric cancer. Methods: CEA levels in peritoneal washes were correlated retrospectively wi th several clinicopathologic factors including clinical outcome in 56 patie nts with resectable gastric cancer. Results: Among several clinicopathologic factors, the depth of tumor invasi on significantly and independently correlated with pCEA levels as revealed by multivariate stepwise logistic regression analysis. A Significant differ ence in overall survival rates was observed between pCEA-positive and pCEA- negative groups: 5-year survival rates were 95.7% in pCEA-negative and 20% in pCEA-positive patients(P <0.0001). Multivariate analysis indicated that pCEA level is a statistically significant independent prognostic factor for the survival of patients with gastric cancer, and is an important factor f or predicting peritoneal recurrence. Conclusions: pCEA could be a potential predictor of a poor prognosis as wel l as peritoneaI recurrence in patients with gastric cancer. We believe that this information could contribute to determining the optimal intraoperativ e and postoperative therapeutic plan including adjuvant chemotherapy of gas tric cancer. (C) 2001 Excerpta Medica, Inc. All rights reserved.